Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Nilotinib may cause gray hair to return to its original color.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

mTOR inhibitors may help treat lung fibrosis.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib is effective as a treatment for severe hair loss.

Baricitinib is a safe and effective treatment for severe alopecia areata.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

JAK inhibitors are effective for long-term management of alopecia areata.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

A woman's hair turned white after taking a cancer drug called dasatinib.